Mayorova A.V.

Mayorova A.V.

Auto-generated profile, based on publicly available information

Mayorova A.V.

Peoples’ Friendship University of Russia, Moscow, Russian Federation

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
AMA. V. Mayorova
A. V. Mayorova
BSBoris Sysuev
Boris Sysuev
JIJ. O. Ivankova
J. O. Ivankova
IHI. A. Hanalieva
I. A. Hanalieva
Коллагеназы в медицинской практике: современные средства на основе коллагеназы и перспективы их совершенствования

12 March 2019 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
YSYu. V. Stepenko
Yu. V. Stepenko
VSVladislav Soldatov
Vladislav Soldatov
MZM. A. Zatolokina
M. A. Zatolokina
AMA. V. Mayorova
A. V. Mayorova
BSBoris Sysuev
Boris Sysuev
MPM. V. Pokrovskiy
M. V. Pokrovskiy
The aim of the article is to evaluate Bischofit gel reparative activity in a linear wound model in rats.Materials and Methods. The study was conducted on 36 male Wistar rats weighing from 193 to 218 grams. On the 8th day after modeling a linear wound defect 50±1 mm long, the reparative effect of bischofite, Actovegin and Contractubex in the gel compositions was evaluated. The evaluation was carried out using: the following methods: 1) studying the physicomechanical characteristics of the wound defect (a wound-tearing machine Metrotest REM-0.2-1); 2) morphological examination of the skin graft taken from the wound area (stained with hematoxylin-eosin and Van Gieson‘s solution); 3) determining the ratio of collagen types I and III in a polarizing microscope (the picrosirius was red); 4) cоlorimetric analysis of the hydroxyproline concentration in the wound surface tissues.Results. On the 8th day, the wound defects sampled from the bischofite treated animals, were characterized by the most pronounced strength (the average force at the rupture moment was 13.70 N), which was significantly higher (p Actovegin (0.67±0.017) > Control (0.56±0.012) > Contractubex (0.38 ±0.020).Conclusion. The carried out study showed that Bischofit has a pronounced ability to stimulate the regeneration of the skin wound defect. Hereby, the reference drug Actovegin showed less activity, and Contractubex worsened wound healing.

30 June 2021 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
MAMayorova A.V.
Mayorova A.V.
BSBoris Sysuev
Boris Sysuev
The collagenase enzyme proteolytic complex used in a gel form will be an alternative to invasive methods and electrophoresis, requiring medical personnel and special equipment. Taking into account the instability of proteolytic enzymes in the aquatic phase, the use of organogel as the collagenase basis makes it possible to create a stable and convenient dosage form for the scar treatment. This study’s aim was the composition of an anti-scar organogel based on Paralithodes camtschatica collagenase development. Aerosil proposed as a thickener. Various technological studies (external signs assessment, distribution on the skin, smearing, pH, proteolytic activity, stability, rheological properties) of gels samples based on lipophilic solvents: dimethicone, cyclomethicone, liquid paraffin, propylene glycol, capril/caprilic triglycerides, were carried out to select the optimal gel-forming agents. The proteolytic activity of the gel with collagenase manifested up to 24 hours, so, it may be used for stabilization. The composition of the components of the dispersion medium, which has acceptable sensory properties for the continuity of treatment, selected. It characterized by thermo- and colloidal stability, acceptable rheological properties. The oleogel on the combination of capril/caprilic triglycerides and dimethicone as a dispersion and aerosil as a thickener was justified, which may be recommended as an anti-scar agent for further research.

20 May 2021 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
MAMayorova A.V.
Mayorova A.V.
BSBoris Sysuev
Boris Sysuev
SYSysueva Y.V.
Sysueva Y.V.
The development of new means for topical therapy and prevention of scar formation of moisturizing and protective action based on ectoin can be promising. The optimal form is hydrogels, because of their adhesive and plastic properties, easily distribution and remaining for a long time on the skin. The purpose of this study was the development of the composition and technological research of the gel with ectoin for the prevention of skin scars. To select the optimal gel-forming agents’ technological studies (external characteristics, drying characteristics and film quality on the skin and on model surfaces, skin moisture, pH, the active substance release, thermal and colloidal stability, rheological properties) of model samples based on gel-forming agents, used in protective and anti-scar creams carried out. The composition of polymers xanthan and sodium carboxymethyl cellulose selected, which has improved adhesion and moisturizing properties, to reduce the frequency of application and provide a prolonged effect. The optimal concentration of dimethicone to enhance the protective effect and enhance the hydrophobic effect selected. The technological characteristics of model samples of ectoin gel investigated: description, pH, thermal and colloidal stability, viscosity, microbiological purity. The results indicate that the gel has the necessary technological characteristics that determine its quality. Thus, as a result of technological research, the composition of the anti-scar ectoin gel was developed.

20 May 2021 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
MAMayorova A.V.
Mayorova A.V.
BSBoris Sysuev
Boris Sysuev
The development of an external gel containing purified bischofite will allow the scars treatment in the stage of prevention and formation due to the effect on various links of pathological wound healing. This study’s aim was the development of a gel with bischofite for the scars prevention and treatment. Bischofite brine from the purified Volgograd deposit was selected as the active pharmaceutical substance. Polymer gelling agents: methylcellulose-100, sodium carboxymethyl cellulose, hydroxymethyl cellulose, aerosil, Tizol®. The QTPP requirements for developed bischofite gel are aimed at effective wound healing and prevention of pathological scarring, which corresponds to the ointments used at the III stage of the wound process. Comprehensive technological studies of model samples of gels with bischofite were carried out: determination of external signs and the application to the skin, smearing, thermal stability and pH, study of osmotic activity and release of bischofite (in terms of magnesium ions). The maximum amount (8 points) was observed in the composition using the Tizol® gel-forming agent, the model sample based on it provided the maximum degree of release, minimal osmotic activity, and good smearing. In addition, Tizol® possesses anti-inflammatory activity. The optimal concentration of the aqueous phase is justified by the assessment of the consistency properties, the spreadability and rheological properties. Thus, as a result the composition of the bischofite gel was developed using Tizol® as a base, containing glycerin as a plasticizer and a moisture agent, the preservative sodium benzoate and purified water.